Valneva SE - ADR
VALN - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$515.84M
Close$
$-3.96
169.5% downside
Current Fair Value
169.5% downsideOvervalued by 169.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $515.84 Million |
|---|---|
| Enterprise Value | $604.99 Million |
| Earnings per Share | $-1.32 |
| Beta | 1.35 |
| Outstanding Shares | 94,823,457 |
Return
| Return on Equity | -195.06% |
|---|---|
| Return on Assets | -40.75% |
| Return on Invested Capital | -41.44% |
Valuation & Multiples
| P/E Ratio | -2.73 |
|---|---|
| PEG | -1.57 |
| Price to Sales | 5.7 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 4.22 |
| Enterprise Value to EBIT | -5.13 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.35 |
| Debt to Equity | 2.6 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.28
Consensus analyst estimateRevenue Estimate
$48.21 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 19, 2026
EPS Estimate
$-0.23
Consensus analyst estimateRevenue Estimate
$43.67 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 3.99% |
|---|---|
| Total Invested | $2,845▼ 99.99% |
| Investors Holding | 1▼ 19.00% |
About Valneva SE
674 employees
CEO: Thomas Lingelbach
Founded in Saint-Herblain, France, in 1998, Valneva SE operates as a specialized biotechnology firm, concentrating on the creation and global distribution of preventative vaccines. Its primary focus is on infectious diseases for which cu...